Aktis Oncology, Inc.

Venture-backed company · Stage unknown· Boston, MA
Rounds on record
1
Latest round
Sep 20, 2024
Form D equity offering
Latest round size
$175M
Form D industry: Biotechnology

Public company. Publicly listed (AKTS); its private filings are not venture rounds.

More
As of · the latest observation of this company; each round carries its own date

3 additional officers and directors

Every relationship, signal and contact on this record, with the source on each.

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

What matters now

  1. 2 investors
    named

    2 investors on record.

    The investors already on the cap table shape who leads the next round.

    Factfunding announcements, portfolio pages and Form DFor Investors, foundersInvestors →
  2. 6 directors
    board

    6 directors on record from Form D filings and board-seat attributions.

    The board is who decides on the next round and on a sale.

    FactSEC Form D related personsFor Investors, acquirersPeople →
Drawing the relationship network…

Facts

Year of incorporation
2020sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
2

Financing history

1 round
  1. Sep 20, 2024
    Form D equity offering · $175M (form d sold) · 39 investors
    Fact Form D · “Aktis Oncology, Inc. filed Form D: $175,000,000 sold of $175,000,000, Biotechnology”

Investors on record

3 edges

Ownership and outcomes

none on record
Outcome stated by investors

Listed on 2 firm portfolio pages; none states an outcome (acquired, public, exited or active). DFX does not assume the company is active.

Evidence: 2 listingseach firm's own card, as read
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.

Credit relationships

none on record
No lender position matched to this company.

People

2 officers, 6 directors

Timeline

1 event
  1. Oct 2, 2024
    Aktis Oncology, Inc. filed Form D: $175,000,000 sold of $175,000,000, Biotechnology
    Form D filed Fact Form D

Evidence

25 observations
Every observation on this company
  • Description: Sep 15, 2026 Fact
  • Entity type: Corporation Oct 2, 2024 Fact Form D
  • Form D industry group: Biotechnology Oct 2, 2024 Fact Form D
  • Amendment: false Oct 2, 2024 Fact Form D
  • Revenue range (Form D): Decline to Disclose Oct 2, 2024 Fact Form D
  • Incorporated: withinFiveYears Oct 2, 2024 Fact Form D
  • Jurisdiction: Delaware Oct 2, 2024 Fact Form D
  • Amount sold (Form D): $175M Oct 2, 2024 Fact Form D
  • Offering amount (Form D): $175M Oct 2, 2024 Fact Form D
  • Exemptions: 06b Oct 2, 2024 Fact Form D
  • First sale: 2024-09-20 Oct 2, 2024 Fact Form D
  • Investors (Form D): 39 Oct 2, 2024 Fact Form D
  • Minimum investment (Form D): 0 Oct 2, 2024 Fact Form D
  • Securities offered: equity Oct 2, 2024 Fact Form D
  • Office address: Oct 2, 2024 Fact Form D
  • Listed on portfolio page: Pappas Ventures Oct 1, 2026 Fact Firm website
  • Listed on portfolio page: MPM Bioimpact Sep 30, 2026 Fact Firm website
  • Listed on portfolio page: MPM Bioimpact Sep 16, 2026 Fact Firm website
  • Listed on portfolio page: Pappas Ventures Sep 16, 2026 Fact Firm website
  • Listed on portfolio page: Pappas Ventures Sep 15, 2026 Fact Firm website
  • Listed on portfolio page: MPM Bioimpact Sep 14, 2026 Fact Firm website
  • Listed on portfolio page: MPM Bioimpact Sep 14, 2026 Fact Firm website
  • Website status: ok Sep 15, 2026 Fact
  • Site title: Sep 15, 2026 Fact
  • Year of incorporation: 2020 Oct 2, 2024 Fact Form D

Relationships across DFX

on 1 other DFX graph
Across the graphs

Aktis Oncology, Inc. is the same institution as 1 record in Private Equity.

Private Equity1

The joined record opens with the product, beside every other relationship on this page.

Checking your plan…

Record history

1 identity change, 1 dated event on the change ledger, latest event first
  • Merged in
    2026-10-01
  • Form D filed
    2024-10-02source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.